• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 22

alpha-Amylase derived from Bacillus licheniformis carrying a gene encoding a modified alpha-amylase derived from Bacillus lichenformis and Bacillus amyloliquefaciens

Intended Use: Use in the starch industry (for the liquefaction of starch in the production of syrups), and in the alcohol industry (for the thinning of starch in distilling mashes) as a processing aid at minimum levels necessary to accomplish the intended technical effect in accordance with current good manufacturing practices
Basis: Scientific procedures
Notifier: Novo Nordisk
Notifier Address: 77 Perry Chapel Church Rd., Box 576; Franklinton, NC 27525
Date of filing: May 24, 1999
GRAS Notice (releasable information): GRN 22 (in PDF)
Date of closure: Dec 29, 1999
FDA's Letter: FDA has no questions